Aspirin Reduces the Potentiating Effect of CD40L on Platelet Aggregation via Inhibition of Myosin Light Chain

BACKGROUND: Antiplatelet therapy with aspirin (acetylsalicylic acid [ASA]) is less efficient in some coronary patients, which increases their risk of developing thrombosis. Elevated blood levels of thromboinflammatory mediators, like soluble CD40L (sCD40L), may explain such variabilities. We hypothe...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Am Heart Assoc
Hoofdauteurs: Kojok, Kevin, Mohsen, Mira, El Kadiry, Abed El Hakim, Mourad, Walid, Merhi, Yahye
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2020
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7033871/
https://ncbi.nlm.nih.gov/pubmed/32009527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.013396
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items